QuantCapitol. Congressional Trading Intelligence

Updated nightly · Public disclosure record

72AVG SCORE

Tina Smith

Senate Democrat MN
Food and Nutrition, Specialty Crops, Organics, and ResearchLivestock, Dairy, Poultry, and Food SafetyRural Development, Energy, and CreditEconomic PolicyHousing, Transportation, and Community DevelopmentFiscal Responsibility and Economic GrowthHealth CareInternational Trade, Customs, and Global CompetitivenessDigital Assets

Tina Smith has disclosed 46 stock transactions — 12 buys, 16 sells and 18 other (exchanges/other), each ranked by how much scrutiny it deserves and linked to its original Senate filing. A transparency record.

Last disclosed trade 2026-05-07 · last filing 2026-05-10

⚑
15 potential conflicts of interest. Smith sits on committee(s) overseeing Agriculture, Finance, Food & Agriculture, Health, Insurance, Transportation, and made 15 trades in those sectors (marked ⚑ below). This is a transparency signal, not an allegation of wrongdoing — such trades are often entirely legitimate.
46
Total trades
12
Buy
16
Sell
18
Other (exchange)
32
Avg. disclosure delay (days)
Trading profile
Occasional: 8 trades in the past year Health-heavy (66% of trades) Mostly spouse accounts 43% buys Typical size $100K–$250K 19 different stocks 84% in sectors their committees oversee
A description of the disclosed trades, not a judgement: it says nothing about skill, intent or future returns.

Track record Congressional Trading Performance

Two figures per horizon, both hypothetical and not investment advice: Member's own — what the trade returned if you'd bought when Smith did (not public yet, so not replicable); and If you'd followed — buying only after the disclosure went public, which is what a follower could actually do. The gap between them is the cost of the disclosure lag.

1 month
Member's own
+14.5%
+11.6% vs S&P 500
If you'd followed
+19.1%
+15.6% vs S&P 500
4 of 7 priced
3 months
Member's own
+12.9%
+5.7% vs S&P 500
If you'd followed
+19.9%
+11.9% vs S&P 500
4 of 7 priced
6 months
Member's own
+22.7%
+13.9% vs S&P 500
If you'd followed
+30.0%
+18.6% vs S&P 500
4 of 7 priced
1 year
Member's own
+68.4%
+44.0% vs S&P 500
If you'd followed
+66.6%
+44.0% vs S&P 500
4 of 7 priced
3 years
Member's own
+99.7%
+26.4% vs S&P 500
If you'd followed
+113.4%
+197.4% vs S&P 500
3 of 7 priced · 1 too recent

The count falls at longer horizons because recent trades haven't completed the full window yet — a return that hasn't happened is never estimated (no look-ahead). Only buys with usable price data are counted.

Round-trip watch Open positions

Stocks Smith disclosed buying and has not disclosed selling, versus their entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised. Not investment advice.

TickerEntry (last buy)Entry priceNowvs entryStatus
TCMD 2024-11-12 $15.75 $26.86 +70.5% in profit
AORT 2023-11-16 $14.09 $18.16 +28.9% in profit

Price as of 2026-11-13. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Where they trade Favorite Sectors

Distribution of this politician's trades across sectors (of trades with a known sector — bonds and funds are excluded).

Health
21 (66%)
Technology
4 (12%)
Insurance
3 (9%)
Food & Agriculture
2 (6%)
Finance
1 (3%)
Utilities
1 (3%)

Traded the same stocks, same time Co-Investors in Congress

Other members who traded the same tickers within 30 days of Smith's trades in them. A high overlap can reflect shared information, shared advisors, or simply popular stocks — it is not evidence of coordination.

PoliticianOverlapping tradesShared tickers
Rohit Khanna 15 DXCM, GIS, MDT, NEE, PEP, PODD
Michael McCaul 2 DXCM
Josh Gottheimer 2 ABT, MMM
Alan Armstrong 2 BRK-B, MMM
Julie Johnson 2 PEP
Kathy Manning 2 MDT
Gilbert Cisneros 1 BRK-B
August Lee Pfluger 1 BRK-B
Mark Alford 1 BRK-B
Christian Menefee 1 BRK-B
William Keating 1 PEP
Rob Bresnahan 1 PEP

Corporate insiders · SEC Form 4 Overlap with Insiders

On the trades where corporate insiders were also active, how often did Tina Smith move the same way as the company's own officers and directors (within 60 days)? Co-occurrence only — context from public Form 4 filings, never proof of coordination, and tested honestly for whether it means anything.

19%
of checkable trades converged
avg 19% across all members
3
converged (of 16 checkable)
4
diverged

Tina Smith's convergence rate of 19% is in line with the 19% average across all members. "Checkable" = trades on tickers where insiders were also trading, so convergence could even be measured.

Descriptive only — insider convergence is context from public SEC Form 4 filings, never proof of coordination or wrongdoing, and not investment advice.

Trade → disclosure Timeline

Each bar runs from the day Tina Smith made a trade to the day it was disclosed, so the gap between the two is the stretch when only the member knew about it. Rows are the 3 most-traded tickers of the last two years. Dashed lines mark activity on bills in sectors Smith's committees oversee. Hover for details. Timing only, never proof of anything.

Buy (trade → disclosure) Sell (trade → disclosure) Bill activity in an overseen sector
Bills on the timeline (10)
  • HRES 1673 — Supporting the goals and ideals of "National Rural Health Day". (2026-11-19, Health)
  • S 5718 — Trucker Bathroom Access Act (2026-11-12, Transportation)
  • HR 10887 — Protecting Consumer Access to Generic Drugs Act of 2026 (2026-10-22, Health)
  • HR 10874 — Medicare Low Income Subsidy Equality Act of 2026 (2026-10-22, Health)
  • HR 10858 — CARE for Blood Cancer Act of 2026 (2026-10-22, Health)
  • HR 10820 — Epstein Wall Street Records Act of 2026 (2026-10-15, Finance)
  • HR 10821 — To amend the Federal Deposit Insurance Act to make changes to the Standard Maximum Deposit Insurance Amount, and for oth (2026-10-15, Finance)
  • HR 10810 — National Patient Safety Board Act of 2026 (2026-10-15, Health)
  • HR 10824 — Stroke Education and EMS Care Improvement Act of 2026 (2026-10-15, Health)
  • HR 10798 — Silicosis Prevention and Treatment Act (2026-10-13, Health)

46 trades Recent Transactions

Marker key: ⚑ potential conflict (a committee Smith sits on oversees that sector) · ◆ corporate-insider overlap from SEC Form 4 (convergence/divergence — context, not a signal) · % of NW trade size vs estimated net worth, 🔥 marking high/extreme conviction · OCR recovered from a scanned filing (verify against source) · ×N filings the same trade disclosed more than once (shown once). None is an allegation of wrongdoing.

TickerCompanyTypeDateFiledLagPrice move
in that
window
AmountScoreSource
PODD Insulet Corp. OTHER 2026-05-07 2026-05-10 3 days -3.9% $100K–$250K 50.6 ↗ eFD · mirror
DXCM Dexcom Inc. OTHER 2026-05-07 2026-05-10 3 days -0.5% $100K–$250K 61.9 ↗ eFD · mirror
⚑ PODD Insulet Corp. SELL ◆ insider divergence · moderate 2026-04-29 2026-05-10 11 days -3.7% $100K–$250K 51.0 ↗ eFD · mirror
⚑ DXCM Dexcom Inc. SELL ◆ insider convergence 2026-04-29 2026-05-10 11 days +5.3% $100K–$250K 83.0 ↗ eFD · mirror
MMM 3M Co. OTHER 2026-03-31 2026-04-02 2 days -0.5% $50K–$100K 93.9 ↗ eFD · mirror
BRK-B Berkshire Hathaway Inc. OTHER 2026-03-31 2026-04-02 2 days -0.4% $100K–$250K 66.9 ↗ eFD · mirror
⚑ BRK-B Berkshire Hathaway Inc. SELL ◆ insider convergence 2026-01-27 2026-01-30 3 days +1.2% $100K–$250K 97.1 ↗ eFD · mirror
MRSH Marsh & Mclennan Companies, Inc. OTHER 2026-01-27 2026-01-30 3 days +5.6% $50K–$100K 93.7 ↗ eFD · mirror
HBAN Huntington Bancshares Inc. OTHER 2025-11-21 2025-11-26 5 days +2.5% $100K–$250K 95.9 ↗ eFD · mirror
PEP Pepsico Inc. OTHER 2025-02-11 2025-03-19 36 days +2.6% $100K–$250K 95.6 ↗ eFD · mirror
GIS General Mills Inc. OTHER 2025-02-11 2025-03-19 36 days -0.3% $100K–$250K 95.6 ↗ eFD · mirror
⚑ TCMD Tactile Systems Technology Inc. BUY 2024-11-12 2024-11-21 9 days +1.2% $50K–$100K 46.7 ↗ eFD · mirror
⚑ PODD Insulet Corp. SELL ◆ insider convergence 2024-04-04 2024-04-19 15 days — $50K–$100K 30.4 ↗ eFD · mirror
NEE Nextera Energy Inc. SELL ◆ insider divergence · moderate 2024-04-04 2024-04-19 15 days — $100K–$250K 95.6 ↗ eFD · mirror
⚑ AORT Artivion, Inc. BUY ◆ insider divergence 2023-11-16 2023-11-20 4 days — $50K–$100K 50.7 ↗ eFD · mirror
⚑ AORT Artivion, Inc. BUY ◆ insider divergence 2023-11-10 2023-11-20 10 days — $50K–$100K 58.8 ↗ eFD · mirror
⚑ TCMD Tactile Systems Technology Inc. BUY 2023-11-08 2023-11-20 12 days — $100K–$250K 57.7 ↗ eFD · mirror
CSII Cardiovascular Systems OTHER 2023-04-05 2023-04-19 14 days — $50K–$100K 92.6 ↗ eFD · mirror
MDT Medtronic plc OTHER 2023-04-05 2023-04-19 14 days — $100K–$250K 95.6 ↗ eFD · mirror
⚑ AORT Artivion, Inc. BUY 2022-09-23 2022-10-17 24 days — $50K–$100K 92.6 ↗ eFD · mirror
— Northern Lakes Capital Iv, Lp BUY 2022-04-04 2022-04-20 16 days — $15K–$50K 53.8 ↗ eFD · mirror
— Tcf Financial (Exchanged) Huntington Bancshares (Received) EXCHANGE 2021-06-09 2022-05-16 341 days — $100K–$250K 65.3 ↗ eFD · mirror
— Surgical Information Sciences BUY 2021-04-11 2021-05-10 29 days — $1K–$15K 37.8 ↗ eFD · mirror
— Surgical Information Sciences BUY 2020-05-01 2020-05-31 30 days — $15K–$50K 53.8 ↗ eFD · mirror
⚑ DXCM Dexcom Inc. SELL 2020-03-17 2020-04-16 30 days — $250K–$500K 96.9 ↗ eFD · mirror
⚑ PODD Insulet Corp. SELL 2020-03-17 2020-04-16 30 days — $250K–$500K 57.2 ↗ eFD · mirror
— Surgical Information Sciences BUY 2019-10-16 2019-10-25 9 days — $15K–$50K 53.8 ↗ eFD · mirror
ABT Abbott Laboratories OTHER 2019-04-09 2019-04-24 15 days — $250K–$500K 96.9 ↗ eFD · mirror
MSTY-PA Mainstay Medical International BUY 2018-10-30 2018-11-14 15 days — $50K–$100K 58.8 ↗ eFD · mirror
MSTY-PA Mainstay Medical International BUY 2018-10-29 2018-11-14 16 days — $50K–$100K 92.6 ↗ eFD · mirror
⚑ PODD Insulet Corp. SELL 2018-08-30 2018-09-19 20 days — $15K–$50K 45.2 ↗ eFD · mirror
CUTR Cutera OTHER 2018-08-30 2018-09-19 20 days — $100K–$250K 65.3 ↗ eFD · mirror
CUTR Cutera OTHER 2018-08-30 2018-09-19 20 days — $1K–$15K 37.8 ↗ eFD · mirror
PODD Insulet Corp. OTHER 2018-08-30 2018-09-19 20 days — $250K–$500K 62.9 ↗ eFD · mirror
IIN Intricon SELL 2018-07-26 2018-08-21 26 days — $100K–$250K 95.6 ↗ eFD · mirror
— Surgical Information Sciences BUY 2018-06-28 2019-10-23 482 days — $15K–$50K 53.8 ↗ eFD · mirror
⚑ TCMD Tactile Systems Technology Inc. SELL 2018-06-01 2018-06-11 10 days — $100K–$250K 95.6 ↗ eFD · mirror
TCMD Tactile Systems Technology Inc. OTHER 2018-06-01 2018-06-11 10 days — $100K–$250K 95.6 ↗ eFD · mirror
⚑ PODD Insulet Corp. SELL 2018-06-01 2018-06-11 10 days — $100K–$250K 65.3 ↗ eFD · mirror
CGNT Cognyte Software Ltd. SELL 2018-04-12 2018-04-20 8 days — $15K–$50K 45.2 ↗ eFD · mirror
CGNT Cognyte Software Ltd. OTHER 2018-04-12 2018-04-20 8 days — $100K–$250K 57.7 ↗ eFD · mirror
CGNT Cognyte Software Ltd. SELL 2018-04-10 2018-04-20 10 days — $15K–$50K 53.8 ↗ eFD · mirror
CGNT Cognyte Software Ltd. SELL 2018-03-29 2018-04-09 11 days — $1K–$15K 73.3 ↗ eFD · mirror
⚑ PODD Insulet Corp. SELL 2018-03-02 2018-03-06 4 days — $100K–$250K 95.6 ↗ eFD · mirror
CUTR Cutera SELL 2018-01-16 2018-01-29 13 days — $250K–$500K 96.9 ↗ eFD · mirror
ENTL Entellus Medical OTHER 2018-01-05 2018-01-29 24 days — $50K–$100K 92.6 ↗ eFD · mirror

FAQ Common questions

How many stock trades has Tina Smith disclosed?

46 disclosed stock transactions — 12 buys and 16 sells — all from official Senate financial disclosures.

Is this insider trading?

No. QuantCapitol surfaces the timing and context of publicly disclosed trades for transparency. A trade near related legislation is a coincidence we flag — never an accusation of wrongdoing.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

Embed Tina Smith's latest trades on your site

A small card with the latest disclosed trades that updates by itself. Free to use with the link back to QuantCapitol left in. Add ?theme=light to the address for a white card.

Writing about it? See the press page.
About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.